PROK — Prokidney Cashflow Statement
0.000.00%
- $874.02m
- $1.92bn
- $0.08m
Annual cashflow statement for Prokidney, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -26.7 | -55.1 | -148 | -135 | -163 |
| Depreciation | |||||
| Non-Cash Items | 0.73 | 0.699 | 74.5 | 24.9 | 27.6 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.126 | 2.16 | -6.46 | 16.7 | 3.96 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Cash from Operating Activities | -25.2 | -50.3 | -77.1 | -90.1 | -126 |
| Capital Expenditures | -5.46 | -5.19 | -1.85 | -34.2 | -29.5 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0.001 | 0.108 | -296 | 49.9 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -5.46 | -5.19 | -1.74 | -330 | 20.4 |
| Financing Cash Flow Items | — | — | — | — | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 20 | 71.5 | 549 | -9.55 | 144 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -10.6 | 16 | 470 | -430 | 38.5 |